| 5001 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T381 | ECGA000381 | 0.52 |
| 5002 | DTI TBSS FA Posterior thalamic radiation R | GCST90384408 | 0.52 |
| 5003 | Cholesteryl Esters in Small LDL | GCST90499586 | 0.52 |
| 5004 | Left hippocampal volume (body) | GCST90267948 | 0.52 |
| 5005 | GBA1 levels | GCST90423262 | 0.52 |
| 5006 | T1 FIRST volume L Hipp | GCST90383990 | 0.52 |
| 5007 | Omega-3 fatty acids to total fatty acids percentage | GCST90502090 | 0.52 |
| 5008 | DTI TBSS L3 Superior fronto-occipital fasciculus R | GCST90384566 | 0.52 |
| 5009 | Placental weight (fetal genotype, adjusted for sex and gestational age) | GCST90275189 | 0.52 |
| 5010 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T160 | ECGA000160 | 0.52 |
| 5011 | Vitamin and mineral supplements - Multivitamins +/- minerals | Medication | UKBB00000900 | 0.52 |
| 5012 | Concentration of small HDL particles | GCST90499464 | 0.52 |
| 5013 | IDP dMRI ProbtrackX L3 str l | GCST90004323 | 0.52 |
| 5014 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T340 | ECGA000340 | 0.52 |
| 5015 | Phospholipids in medium VLDL | GCST90499025 | 0.52 |
| 5016 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T148 | ECGA000148 | 0.52 |
| 5017 | SCARA3 levels | GCST90427856 | 0.52 |
| 5018 | Triglycerides to Total Lipids in Medium HDL percentage | GCST90498682 | 0.52 |
| 5019 | Working memory | GCST90503116 | 0.52 |
| 5020 | C8B levels | GCST90468503 | 0.52 |
| 5021 | Triglycerides to Total Lipids in Very Large HDL percentage | GCST90500508 | 0.51 |
| 5022 | Total lipids in very large VLDL | GCST90500614 | 0.51 |
| 5023 | DTI autoptx L3 slf l tract | GCST90385214 | 0.51 |
| 5024 | Free cholesterol in large HDL | GCST90497780 | 0.51 |
| 5025 | LRIG1 levels | GCST90469794 | 0.51 |
| 5026 | Frequency of tenseness / restlessness in last 2 weeks | Mental health | UKBB00000267 | 0.51 |
| 5027 | ENO2/PRSS27 ratio | GCST90314666 | 0.51 |
| 5028 | ERBB4/F3 ratio | GCST90314690 | 0.51 |
| 5029 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T204 | ECGA000204 | 0.51 |
| 5030 | CD2AP/USP8 ratio | GCST90313784 | 0.51 |
| 5031 | CLIP2/DAB2 ratio | GCST90314124 | 0.51 |
| 5032 | TNFRSF1A levels | GCST90012015 | 0.51 |
| 5033 | Average weekly beer plus cider intake | Alcohol | UKBB00000082 | 0.51 |
| 5034 | Left-hemisphere dorsal attention network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302695 | 0.51 |
| 5035 | Carcinoma in situ of breast, intraductal (controls excluding all cancers) | FING00000240 | 0.51 |
| 5036 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T187 | ECGA000187 | 0.51 |
| 5037 | Bursitis (PheCode 726.3) | GCST90476240 | 0.51 |
| 5038 | GIMAP7 levels | GCST90469345 | 0.51 |
| 5039 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T95 | ECGA000095 | 0.51 |
| 5040 | Triglycerides | GCST000758 | 0.51 |
| 5041 | IDP dMRI TBSS MD Cingulum hippocampus L | GCST90004064 | 0.51 |
| 5042 | Right ventricular peak atrial filling rate | GCST90268119 | 0.51 |
| 5043 | GGACT levels | GCST90469333 | 0.51 |
| 5044 | Milk type used - Skimmed | Diet | UKBB00000470 | 0.51 |
| 5045 | ITGA5/VCAM1 ratio | GCST90315206 | 0.51 |
| 5046 | IL22 levels | GCST90469582 | 0.51 |
| 5047 | Monounsaturated fatty acids to total fatty acids percentage | GCST90499111 | 0.51 |
| 5048 | Left-hemisphere dorsal attention network to left-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302690 | 0.51 |
| 5049 | IDP dMRI TBSS ICVF Superior longitudinal fasciculus L | GCST90004368 | 0.51 |
| 5050 | DTI TBSS L2 Retrolenticular part of internal capsule R | GCST90384496 | 0.51 |
| 5051 | GSTT2B levels | GCST90469415 | 0.51 |
| 5052 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T100 | ECGU000100 | 0.51 |
| 5053 | Total lipids in medium VLDL (UKB data field 23503) | GCST90269600 | 0.51 |
| 5054 | SERPINA4 levels | GCST90470584 | 0.51 |
| 5055 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T387 | ECGU000387 | 0.51 |
| 5056 | CD40LG/GP6 ratio | GCST90313822 | 0.50 |
| 5057 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T305 | ECGA000305 | 0.50 |
| 5058 | IDP T1 FAST ROIs R cerebellum X | GCST90002589 | 0.50 |
| 5059 | F-deep fried food liking (derived food-liking factor) | GCST90094753 | 0.50 |
| 5060 | KLB levels | GCST90469693 | 0.50 |
| 5061 | IDP dMRI TBSS ICVF Uncinate fasciculus L | GCST90004372 | 0.50 |
| 5062 | Exotropia | GCST90572737 | 0.50 |
| 5063 | DAPP1/SDC4 ratio | GCST90314399 | 0.50 |
| 5064 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T240 | ECGU000240 | 0.50 |
| 5065 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T83 | ECGA000083 | 0.50 |
| 5066 | Plasma mannonate* levels in chronic kidney disease | GCST90265479 | 0.50 |
| 5067 | DTI autoptx L3 ilf l tract | GCST90385207 | 0.50 |
| 5068 | 1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) levels | GCST90200070 | 0.50 |
| 5069 | IDP dMRI ProbtrackX FA atr r | GCST90003928 | 0.50 |
| 5070 | TXNL1 levels | GCST90470993 | 0.50 |
| 5071 | Sleep disorders (PheCode 327) | GCST90475823 | 0.50 |
| 5072 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T223 | ECGU000223 | 0.50 |
| 5073 | MPIG6B/PLXNA4 ratio | GCST90315483 | 0.50 |
| 5074 | CAMK1D levels | GCST90240556 | 0.50 |
| 5075 | Cholesteryl esters in medium HDL (UKB data field 23569) | GCST90269666 | 0.50 |
| 5076 | Triglycerides x anxiety interaction (2df test) | GCST90570677 | 0.50 |
| 5077 | F5 levels | GCST90446466 | 0.50 |
| 5078 | CETN2/PRTFDC1 ratio | GCST90314030 | 0.50 |
| 5079 | GPIHBP1 levels | GCST90469390 | 0.50 |
| 5080 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T449 | ECGA000449 | 0.50 |
| 5081 | Osteoarthritis, localized (PheCode 740.1) | GCST90476254 | 0.50 |
| 5082 | DNA methylation-estimated granulocyte proportions | GCST90014287 | 0.50 |
| 5083 | SERPINB9 levels | GCST90470593 | 0.50 |
| 5084 | NGRN levels | GCST90470045 | 0.50 |
| 5085 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502648 | 0.50 |
| 5086 | Cholesterol in Small LDL | GCST90499555 | 0.50 |
| 5087 | IDP dMRI TBSS FA Splenium of corpus callosum | GCST90003881 | 0.50 |
| 5088 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T302 | ECGA000302 | 0.50 |
| 5089 | APOA1 levels | GCST90497122 | 0.50 |
| 5090 | Hyphaema and other vascular disorders of iris and ciliary body | FING00000647 | 0.50 |
| 5091 | Triacylglycerol_58:7_[M+NH4]1+ levels | GCST90060564 | 0.50 |
| 5092 | Medication for pain relief, constipation, heartburn - Paracetamol | Medication | UKBB00000459 | 0.50 |
| 5093 | Saturated fatty acids to total fatty acids percentage | GCST90499958 | 0.50 |
| 5094 | FAM13A levels | GCST90469181 | 0.50 |
| 5095 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 65) | GCST90320884 | 0.50 |
| 5096 | CCN2/MGLL ratio | GCST90313714 | 0.50 |
| 5097 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T382 | ECGA000382 | 0.50 |
| 5098 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T337 | ECGU000337 | 0.50 |
| 5099 | Right-hemisphere somatomotor network to right-hemisphere control network white-matter structural connectivity | GCST90302792 | 0.49 |
| 5100 | Triglycerides to total lipids in very large HDL percentage (UKB data field 23633) | GCST90269730 | 0.49 |
| 5101 | Snoring | Sleep | UKBB00000784 | 0.49 |
| 5102 | IDP dMRI ProbtrackX ICVF slf r | GCST90004397 | 0.49 |
| 5103 | IDP dMRI ProbtrackX FA ptr r | GCST90003945 | 0.49 |
| 5104 | EGLN1/PIK3AP1 ratio | GCST90314619 | 0.49 |
| 5105 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T301 | ECGA000301 | 0.49 |
| 5106 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T297 | ECGU000297 | 0.49 |
| 5107 | CCL17/THPO ratio | GCST90313689 | 0.49 |
| 5108 | Concentration of chylomicrons and extremely large VLDL particles | GCST90093047 | 0.49 |
| 5109 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T147 | ECGA000147 | 0.49 |
| 5110 | Blood cell traits latent factor 7 (white cell) | GCST90559249 | 0.49 |
| 5111 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T181 | ECGU000181 | 0.49 |
| 5112 | IL4R levels | GCST90469598 | 0.49 |
| 5113 | IGSF8/NECTIN2 ratio | GCST90315140 | 0.49 |
| 5114 | IL18BP levels | GCST90469564 | 0.49 |
| 5115 | HippSubfield lh volume Whole-hippocampal-body | GCST90002687 | 0.49 |
| 5116 | White blood cell count | GCST90025985 | 0.49 |
| 5117 | DTI autoptx L2 str l tract | GCST90385189 | 0.49 |
| 5118 | Docosahexaenoic acid to total fatty acids percentage | GCST90502281 | 0.49 |
| 5119 | Left-hemisphere salience/ventral attention network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302714 | 0.49 |
| 5120 | Triglyceride levels in chylomicrons and extremely large VLDL | GCST90093050 | 0.49 |
| 5121 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T332 | ECGU000332 | 0.49 |
| 5122 | CPXM1 levels | GCST90468849 | 0.49 |
| 5123 | Phospholipids in IDL | GCST90497628 | 0.49 |
| 5124 | RILP/RWDD1 ratio | GCST90315778 | 0.49 |
| 5125 | Phospholipids in VLDL (UKB data field 23412) | GCST90269509 | 0.49 |
| 5126 | Acne | FING00000010 | 0.49 |
| 5127 | Concentration of HDL particles (UKB data field 23430) | GCST90269527 | 0.49 |
| 5128 | IDP dMRI TBSS OD Superior corona radiata L | GCST90004427 | 0.49 |
| 5129 | CDKN2D/MANF ratio | GCST90313989 | 0.49 |
| 5130 | PPIE levels | GCST90242217 | 0.49 |
| 5131 | PPP2R5A levels | GCST90470306 | 0.49 |
| 5132 | IDP dMRI TBSS ISOVF External capsule R | GCST90004509 | 0.48 |
| 5133 | Phospholipids to total lipids ratio in small HDL | GCST90092953 | 0.48 |
| 5134 | Triglycerides to Total Lipids in Small VLDL percentage | GCST90499934 | 0.48 |
| 5135 | COL18A1/RETN ratio | GCST90314170 | 0.48 |
| 5136 | Cirrhosis | GCST90018606 | 0.48 |
| 5137 | FSTL3 levels | GCST90469272 | 0.48 |
| 5138 | RPN1 levels | GCST90240964 | 0.48 |
| 5139 | Total cholesterol levels | GCST90239675 | 0.48 |
| 5140 | X-21286 levels | GCST90200562 | 0.48 |
| 5141 | SLURP1 levels | GCST90470674 | 0.48 |
| 5142 | FAM3B levels | GCST90469186 | 0.48 |
| 5143 | Total lipid levels in HDL | GCST90092825 | 0.48 |
| 5144 | Free Cholesterol to Total Lipids in Large HDL percentage | GCST90497790 | 0.48 |
| 5145 | aparc-DKTatlas rh volume fusiform | GCST90002898 | 0.48 |
| 5146 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T151 | ECGU000151 | 0.48 |
| 5147 | MEGF9/OXT ratio | GCST90315419 | 0.48 |
| 5148 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T214 | ECGU000214 | 0.48 |
| 5149 | MPHOSPH8/PSRC1 ratio | GCST90315478 | 0.48 |
| 5150 | Reticulocyte count | GCST90025972 | 0.48 |
| 5151 | ARTN levels | GCST90468372 | 0.48 |
| 5152 | PTPRC levels | GCST90470380 | 0.48 |
| 5153 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 30) | GCST90320849 | 0.48 |
| 5154 | Calculus of kidney and ureter | FING00000236 | 0.48 |
| 5155 | CD300LG/CLEC14A ratio | GCST90313801 | 0.48 |
| 5156 | FGFBP1 levels | GCST90469230 | 0.48 |
| 5157 | IL18BP/THBD ratio | GCST90315156 | 0.48 |
| 5158 | Treatment or medication use - ezetimibe (UKB data field 20003_1141192736) | GCST90042541 | 0.48 |
| 5159 | RP2 levels | GCST90470493 | 0.48 |
| 5160 | SNCA levels | GCST90240258 | 0.47 |
| 5161 | Enthesopathies of lower limb, excluding foot | FING00000509 | 0.47 |
| 5162 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T248 | ECGA000248 | 0.47 |
| 5163 | Total lipids in large HDL | GCST90497818 | 0.47 |
| 5164 | AZU1 levels | GCST90468408 | 0.47 |
| 5165 | total cholesterol (mean, inv-norm transformed) | GCST90476424 | 0.47 |
| 5166 | Isolated hypothyroxinemia in pregnancy | GCST90435198 | 0.47 |
| 5167 | X-12216 levels | GCST90200483 | 0.47 |
| 5168 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502168 | 0.47 |
| 5169 | BCAN/MOG ratio | GCST90313480 | 0.47 |
| 5170 | wg lh intensity-contrast lateraloccipital | GCST90003802 | 0.47 |
| 5171 | Pneumonia | GCST90018681 | 0.47 |
| 5172 | SIGLEC7 levels | GCST90470635 | 0.47 |
| 5173 | IDP dMRI ProbtrackX ISOVF str l | GCST90004548 | 0.47 |
| 5174 | Optic disc area | GCST004076 | 0.47 |
| 5175 | LGALS9/SIGLEC1 ratio | GCST90315323 | 0.47 |
| 5176 | Linoleic acid to total fatty acids percentage | GCST90502332 | 0.47 |
| 5177 | Saturated fatty acids levels | GCST90502659 | 0.47 |
| 5178 | CD84/GP1BA ratio | GCST90313913 | 0.47 |
| 5179 | Lymphocyte count | GCST90018742 | 0.47 |
| 5180 | Phospholipid levels in very large VLDL | GCST90093024 | 0.47 |
| 5181 | Allergic conjunctivitis | FING00000067 | 0.47 |
| 5182 | Citrate levels | GCST90092813 | 0.47 |
| 5183 | RNASE6 levels | GCST90470479 | 0.47 |
| 5184 | PFKFB2 levels | GCST90470215 | 0.47 |
| 5185 | Cholesterol to total lipids in very large HDL percentage (UKB data field 23630) | GCST90269727 | 0.47 |
| 5186 | aseg rh number HolesBeforeFixing | GCST90002647 | 0.47 |
| 5187 | GP2/LGALS8 ratio | GCST90314961 | 0.47 |
| 5188 | Total lipids in large VLDL | GCST90498216 | 0.47 |
| 5189 | Glycerophosphorylcholine (GPC) levels | GCST90199629 | 0.47 |
| 5190 | THPO levels | GCST90470857 | 0.47 |
| 5191 | Triglycerides in small LDL (UKB data field 23550) | GCST90269647 | 0.47 |
| 5192 | CPA4 levels | GCST90468838 | 0.47 |
| 5193 | Total bile acid levels in pregnancy | GCST90454198 | 0.47 |
| 5194 | Cholesteryl Esters in Medium VLDL | GCST90498928 | 0.46 |
| 5195 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T190 | ECGU000190 | 0.46 |
| 5196 | Free cholesterol in medium LDL | GCST90498774 | 0.46 |
| 5197 | RBFOX3 levels | GCST90470432 | 0.46 |
| 5198 | KITLG levels | GCST90469691 | 0.46 |
| 5199 | Drinks usually with meals in current drinkers (yes and it varies vs no) (UKB data field 1618) | GCST90132925 | 0.46 |
| 5200 | Orange juice liking | GCST90094806 | 0.46 |
| 5201 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502384 | 0.46 |
| 5202 | SLIT2 levels | GCST90470668 | 0.46 |
| 5203 | Triacylglycerol_51:2_[M+NH4]1+ levels | GCST90060497 | 0.46 |
| 5204 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T345 | ECGA000345 | 0.46 |
| 5205 | Cholesterol levels in very large VLDL | GCST90093016 | 0.46 |
| 5206 | Right-hemisphere default mode network to amygdala white-matter structural connectivity | GCST90302849 | 0.46 |
| 5207 | DCTN1/SCAMP3 ratio | GCST90314433 | 0.46 |
| 5208 | TIMP3 levels | GCST90470871 | 0.46 |
| 5209 | AGRN/CRIM1 ratio | GCST90313200 | 0.46 |
| 5210 | LSIL lesion of the cervix uteri, vagina or vulva | FING00000733 | 0.46 |
| 5211 | Glycated hemoglobin levels | GCST90566424 | 0.46 |
| 5212 | Major depressive disorder (ICD-10 coded) | GCST005903 | 0.46 |
| 5213 | IDP dMRI ProbtrackX L1 str l | GCST90004269 | 0.46 |
| 5214 | ENPP2 levels | GCST90469115 | 0.46 |
| 5215 | Triglycerides to total lipids ratio in small HDL | GCST90092955 | 0.46 |
| 5216 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T341 | ECGA000341 | 0.46 |
| 5217 | Joint pain (confirmatory factor analysis Factor 14) | GCST90309348 | 0.46 |
| 5218 | TMSB10/TXNRD1 ratio | GCST90315925 | 0.46 |
| 5219 | FAS levels | GCST90427702 | 0.46 |
| 5220 | Triacylglycerol_54:5_[M+NH4]1+ levels | GCST90060539 | 0.46 |
| 5221 | aparc-a2009s rh volume G+S-subcentral | GCST90003002 | 0.46 |
| 5222 | CTSF/CTSV ratio | GCST90314313 | 0.46 |
| 5223 | OGA levels | GCST90470117 | 0.46 |
| 5224 | Inpatient record format - UK HES Inpatients (2017 format) | Summary Administration | UKBB00000365 | 0.46 |
| 5225 | Elevated prostate specific antigen [PSA] (PheCode 796) | GCST90476277 | 0.46 |
| 5226 | PNMA1 levels | GCST90470276 | 0.46 |
| 5227 | BAIAP2 levels | GCST90468419 | 0.46 |
| 5228 | PMVK/PRDX5 ratio | GCST90315694 | 0.46 |
| 5229 | PDGFB levels | GCST90470189 | 0.46 |
| 5230 | ICD10 N83.0, N83.1, N83.2: Ovarian cyst, including follicular cyst, corpus luteum cyst, and other/unspecified ovarian cyst | GCST90454215 | 0.46 |
| 5231 | LEP levels | GCST003368 | 0.46 |
| 5232 | ITGB1BP2/SKAP2 ratio | GCST90315219 | 0.46 |
| 5233 | LRRFIP1 levels | GCST90469805 | 0.46 |
| 5234 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T213 | ECGU000213 | 0.46 |
| 5235 | Total lipid levels in very large HDL | GCST90093010 | 0.46 |
| 5236 | Cholesteryl ester levels in very large VLDL | GCST90093018 | 0.46 |
| 5237 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T379 | ECGA000379 | 0.46 |
| 5238 | SELP levels | GCST90470569 | 0.46 |
| 5239 | CCL13/CCL17 ratio | GCST90313674 | 0.46 |
| 5240 | Phosphate levels (UKB data field 30810) | GCST90468094 | 0.46 |
| 5241 | Calcium levels | GCST90018731 | 0.46 |
| 5242 | DKK3 levels | GCST90468998 | 0.46 |
| 5243 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T209 | ECGA000209 | 0.46 |
| 5244 | Plasma pregnenetriol sulfate* levels in chronic kidney disease | GCST90265866 | 0.46 |
| 5245 | Other diseases of oesophagus | Diseases of oesophagus, stomach and duodenum | UKBB00000606 | 0.46 |
| 5246 | HAVCR1 levels | GCST90012041 | 0.46 |
| 5247 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T202 | ECGU000202 | 0.46 |
| 5248 | aparc-Desikan rh volume fusiform | GCST90002807 | 0.45 |
| 5249 | Fasting plasma glucose | GCST90297787 | 0.45 |
| 5250 | LILRB2 levels | GCST90469777 | 0.45 |
| 5251 | Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80) | GCST90668758 | 0.45 |
| 5252 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T346 | ECGU000346 | 0.45 |
| 5253 | DTI TBSS MD Superior longitudinal fasciculus L | GCST90384613 | 0.45 |
| 5254 | REG1A levels | GCST90470447 | 0.45 |
| 5255 | LTBR/SIRPB1 ratio | GCST90315339 | 0.45 |
| 5256 | CES3 levels | GCST90468720 | 0.45 |
| 5257 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T500 | ECGU000500 | 0.45 |
| 5258 | Benign neoplasm of major salivary glands | FING00000157 | 0.45 |
| 5259 | Treatment/medication code - atenolol | Medications | UKBB00000842 | 0.45 |
| 5260 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T74 | ECGA000074 | 0.45 |
| 5261 | IDP dMRI TBSS ICVF Fornix cres+Stria terminalis R | GCST90004365 | 0.45 |
| 5262 | MUC13 levels | GCST90469963 | 0.45 |
| 5263 | SFTPD levels | GCST90470614 | 0.45 |
| 5264 | aparc-Desikan lh area TotalSurface | GCST90003073 | 0.45 |
| 5265 | Glycoprotein acetyls levels | GCST90497328 | 0.45 |
| 5266 | IL6ST levels | GCST90469603 | 0.45 |
| 5267 | Total lipid levels in very large VLDL | GCST90093022 | 0.45 |
| 5268 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T135 | ECGA000135 | 0.45 |
| 5269 | C19ORF12 levels | GCST90468483 | 0.45 |
| 5270 | STX4 levels | GCST90470772 | 0.45 |
| 5271 | ABL1 levels | GCST90468190 | 0.45 |
| 5272 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T291 | ECGU000291 | 0.45 |
| 5273 | Other retinal disorders | FING00001094 | 0.45 |
| 5274 | PTH1R levels | GCST90470371 | 0.45 |
| 5275 | Saturated fatty acids to total fatty acids percentage | GCST90502207 | 0.45 |
| 5276 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 4) | GCST90320823 | 0.45 |
| 5277 | DTI TBSS L3 Posterior corona radiata L | GCST90384551 | 0.45 |
| 5278 | CD5/IL16 ratio | GCST90313861 | 0.45 |
| 5279 | Total fatty acid levels | GCST90502723 | 0.45 |
| 5280 | SPARC levels | GCST90470718 | 0.45 |
| 5281 | DCTN1 levels | GCST90468958 | 0.45 |
| 5282 | Disorders of vitreous body | FING00000465 | 0.45 |
| 5283 | NELL2 levels | GCST90470027 | 0.45 |
| 5284 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T1 | ECGA000001 | 0.45 |
| 5285 | Right ventricular peak ejection rate | GCST90268120 | 0.45 |
| 5286 | Total Ceramide levels | GCST90025817 | 0.44 |
| 5287 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T177 | ECGU000177 | 0.44 |
| 5288 | Congenital malformations of the circulatory system | FING00000340 | 0.44 |
| 5289 | Cholesteryl Esters in Medium LDL | GCST90498738 | 0.44 |
| 5290 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T96 | ECGA000096 | 0.44 |
| 5291 | IDP dMRI TBSS L3 Posterior corona radiata L | GCST90004198 | 0.44 |
| 5292 | TRIM5 levels | GCST90470970 | 0.44 |
| 5293 | Phosphatidylcholine_38:5_[M+H]1+/Phosphatidylethanolamine_41:5_[M+H]1+/Phosphatidate_43:6_[M+NH4]1+ levels | GCST90060395 | 0.44 |
| 5294 | MIF levels | GCST90469906 | 0.44 |
| 5295 | VSTM2B levels | GCST90471056 | 0.44 |
| 5296 | ABL1/DNMBP ratio | GCST90313149 | 0.44 |
| 5297 | MVK/SERPINE1 ratio | GCST90315505 | 0.44 |
| 5298 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T350 | ECGA000350 | 0.44 |
| 5299 | Atrial fibrillation and flutter | FING00000126 | 0.44 |
| 5300 | ENO3 levels | GCST90469111 | 0.44 |
| 5301 | Cancer of bronchus; lung (PheCode 165.1) | GCST90475573 | 0.44 |
| 5302 | Right-hemisphere limbic network to thalamus white-matter structural connectivity | GCST90302827 | 0.44 |
| 5303 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T338 | ECGU000338 | 0.44 |
| 5304 | Gestational [pregnancy-induced] oedema and proteinuria without hypertension | FING00000572 | 0.44 |
| 5305 | Omega-6 fatty acids to total fatty acids percentage | GCST90502529 | 0.44 |
| 5306 | IDP dMRI ProbtrackX L3 cgc l | GCST90004304 | 0.44 |
| 5307 | Free cholesterol levels in medium HDL | GCST90092896 | 0.44 |
| 5308 | DIABLO/PDGFB ratio | GCST90314468 | 0.44 |
| 5309 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T51 | ECGA000051 | 0.44 |
| 5310 | SNAP23/TXLNA ratio | GCST90315857 | 0.44 |
| 5311 | Indolebutyrate levels | GCST90199759 | 0.44 |
| 5312 | Congenital malformations of heart and great arteries | FING00000336 | 0.44 |
| 5313 | DTI autoptx L2 ilf l tract | GCST90385180 | 0.44 |
| 5314 | Triglyceride levels in very large VLDL | GCST90093026 | 0.44 |
| 5315 | Principal component-derived dietary pattern 32 | GCST90133037 | 0.44 |
| 5316 | DTI autoptx L2 unc r tract | GCST90385192 | 0.44 |
| 5317 | 2-hydroxyisobutyrate levels | GCST90243539 | 0.44 |
| 5318 | IDP dMRI ProbtrackX FA slf r | GCST90003947 | 0.44 |
| 5319 | Spread type - Never/rarely use spread | Diet | UKBB00000794 | 0.44 |
| 5320 | CPE levels | GCST90468841 | 0.44 |
| 5321 | NECTIN4/SPINK5 ratio | GCST90315534 | 0.44 |
| 5322 | Cholesteryl esters in very large VLDL | GCST90500552 | 0.44 |
| 5323 | Degree of unsaturation | GCST90500162 | 0.44 |
| 5324 | SUSD1/THPO ratio | GCST90315899 | 0.44 |
| 5325 | FAM3C levels | GCST90469187 | 0.44 |
| 5326 | Alcohol abuse, main dg (more control exclusions) | FING00000049 | 0.43 |
| 5327 | High cholesterol | GCST90468134 | 0.43 |
| 5328 | High light scatter reticulocyte count | GCST90002385 | 0.43 |
| 5329 | IDP dMRI TBSS FA Superior fronto-occipital fasciculus L | GCST90003920 | 0.43 |
| 5330 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T93 | ECGA000093 | 0.43 |
| 5331 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T412 | ECGU000412 | 0.43 |
| 5332 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T254 | ECGU000254 | 0.43 |
| 5333 | CDH6/NTRK2 ratio | GCST90313962 | 0.43 |
| 5334 | ENTPD5 levels | GCST90241024 | 0.43 |
| 5335 | Free cholesterol in large VLDL | GCST90498185 | 0.43 |
| 5336 | Chronic ulcer of leg or foot (PheCode 707.2) | GCST90476218 | 0.43 |
| 5337 | Right-hemisphere control network to thalamus white-matter structural connectivity | GCST90302836 | 0.43 |
| 5338 | DKK1 levels | GCST90468997 | 0.43 |
| 5339 | IDP dMRI ProbtrackX ISOVF cgc l | GCST90004529 | 0.43 |
| 5340 | Cholesteryl ester_16:0_[M+NH4]1+ levels | GCST90060211 | 0.43 |
| 5341 | Phospholipid levels in chylomicrons and extremely large VLDL | GCST90093048 | 0.43 |
| 5342 | MAP2K6/TBL1X ratio | GCST90315378 | 0.43 |
| 5343 | PALM levels | GCST90470154 | 0.43 |
| 5344 | wg rh intensity-contrast rostralanteriorcingulate | GCST90003852 | 0.43 |
| 5345 | AmygNuclei rh volume Accessory-Basal-nucleus | GCST90002660 | 0.43 |
| 5346 | DTI TBSS L1 External capsule L | GCST90384461 | 0.43 |
| 5347 | Hippocampal subfield left CA3 volume (head) | GCST90267941 | 0.43 |
| 5348 | Total lipids in very small VLDL | GCST90500810 | 0.43 |
| 5349 | Peak expiratory flow (PEF) | Spirometry | UKBB00000638 | 0.43 |
| 5350 | Reticulocyte count | GCST90002405 | 0.43 |
| 5351 | Right-hemisphere limbic network to hippocampus white-matter structural connectivity | GCST90302831 | 0.43 |
| 5352 | Concentration of very large VLDL particles | GCST90093023 | 0.43 |
| 5353 | Left-hemisphere limbic network to hippocampus white-matter structural connectivity | GCST90302740 | 0.43 |
| 5354 | Cholesterol in Small VLDL | GCST90499750 | 0.43 |
| 5355 | Cholesterol in Large HDL | GCST90497719 | 0.43 |
| 5356 | Mixed conductive and sensorineural hearing loss | FING00000827 | 0.43 |
| 5357 | KLK1 levels | GCST90469702 | 0.43 |
| 5358 | aparc-a2009s rh volume S-postcentral | GCST90003065 | 0.43 |
| 5359 | YAP1 levels | GCST90471086 | 0.43 |
| 5360 | T1 FreeSurfer DKT lh superiortemporal thickness | GCST90384252 | 0.43 |
| 5361 | DTI autoptx MD ilf l tract | GCST90385234 | 0.43 |
| 5362 | Total lipids in medium HDL (UKB data field 23566) | GCST90269663 | 0.43 |
| 5363 | GP1BB levels | GCST90469381 | 0.43 |
| 5364 | Ulcerative enterocolitis | FING00001391 | 0.43 |
| 5365 | Cardiomyopathy (PheCode 425) | GCST90475949 | 0.43 |
| 5366 | Right-hemisphere somatomotor network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302788 | 0.43 |
| 5367 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T157 | ECGU000157 | 0.43 |
| 5368 | DTI TBSS L3 Posterior corona radiata R | GCST90384550 | 0.43 |
| 5369 | Ulcerative proctitis | FING00001393 | 0.43 |
| 5370 | Cholesterol esters in very small VLDL | GCST90500740 | 0.43 |
| 5371 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T331 | ECGU000331 | 0.43 |
| 5372 | DTI autoptx MD unc r tract | GCST90385246 | 0.43 |
| 5373 | CD226 levels | GCST90468609 | 0.43 |
| 5374 | HDL x low social support interaction (2df test) | GCST90570669 | 0.42 |
| 5375 | Osteoarthrosis, localized, primary (PheCode 740.11) | GCST90476255 | 0.42 |
| 5376 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 5) | GCST90320568 | 0.42 |
| 5377 | FHIT/GLOD4 ratio | GCST90314817 | 0.42 |
| 5378 | SSC4D levels | GCST90470747 | 0.42 |
| 5379 | CCL11/CCL7 ratio | GCST90313673 | 0.42 |
| 5380 | IDP dMRI TBSS ISOVF Superior longitudinal fasciculus R | GCST90004517 | 0.42 |
| 5381 | Cholesterol to total lipids ratio in medium HDL | GCST90092893 | 0.42 |
| 5382 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502571 | 0.42 |
| 5383 | Constipation | FING00000348 | 0.42 |
| 5384 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T286 | ECGU000286 | 0.42 |
| 5385 | TNFSF12 levels | GCST90274846 | 0.42 |
| 5386 | Ever felt worried, tense, or anxious for most of a month or longer | Anxiety | UKBB00000215 | 0.42 |
| 5387 | Free cholesterol in VLDL (UKB data field 23420) | GCST90269517 | 0.42 |
| 5388 | ADGRE5 levels | GCST90468238 | 0.42 |
| 5389 | DTI TBSS L2 Fornix | GCST90384481 | 0.42 |
| 5390 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T357 | ECGA000357 | 0.42 |
| 5391 | EGF/PPIB ratio | GCST90314612 | 0.42 |
| 5392 | Type 1 diabetes with neurological manifestations (PheCode 250.14) | GCST90475664 | 0.42 |
| 5393 | IL1R1 levels | GCST90469571 | 0.42 |
| 5394 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502554 | 0.42 |
| 5395 | Muscular dystrophy | FING00000848 | 0.42 |
| 5396 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T343 | ECGU000343 | 0.42 |
| 5397 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T258 | ECGA000258 | 0.42 |
| 5398 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T296 | ECGU000296 | 0.42 |
| 5399 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T346 | ECGA000346 | 0.42 |
| 5400 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T447 | ECGA000447 | 0.42 |
| 5401 | Ceramide (d16:1/24:0) levels | GCST90025266 | 0.42 |
| 5402 | DTI TBSS L3 Sagittal stratum R | GCST90384554 | 0.42 |
| 5403 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 44) | GCST90320863 | 0.42 |
| 5404 | GZMA/GZMH ratio | GCST90315008 | 0.42 |
| 5405 | Left-hemisphere visual network to caudate white-matter structural connectivity | GCST90302663 | 0.42 |
| 5406 | CDH1 levels | GCST90468670 | 0.42 |
| 5407 | QPCT levels | GCST90470401 | 0.42 |
| 5408 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T406 | ECGU000406 | 0.42 |
| 5409 | PLXNA4/USP8 ratio | GCST90315690 | 0.42 |
| 5410 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T2 | ECGA000002 | 0.42 |
| 5411 | 3-methyl-2-oxobutyrate levels | GCST90199677 | 0.42 |
| 5412 | Phospholipids to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23579) | GCST90269676 | 0.42 |
| 5413 | IL7 levels | GCST90469606 | 0.42 |
| 5414 | Eicosenoylcarnitine (C20:1) levels | GCST90200148 | 0.42 |
| 5415 | Lysoalkylphosphatidylcholine (O-20:0) levels | GCST90024193 | 0.42 |
| 5416 | CC2D1A/STIP1 ratio | GCST90313665 | 0.42 |
| 5417 | aseg rh intensity Cerebellum-Cortex | GCST90003781 | 0.42 |
| 5418 | Triglycerides in HDL | GCST90497467 | 0.42 |
| 5419 | BA-exvivo rh area BA45 | GCST90003229 | 0.42 |
| 5420 | Linoleic acid to total fatty acids percentage | GCST90502017 | 0.42 |
| 5421 | Cholesterol in Medium VLDL | GCST90498909 | 0.42 |
| 5422 | aparc-Desikan lh area rostralmiddlefrontal | GCST90003099 | 0.42 |
| 5423 | Retinal thickness (functional principal component 3) | GCST90455723 | 0.42 |
| 5424 | Glycerate levels | GCST90200290 | 0.42 |
| 5425 | ICA1/TANK ratio | GCST90315112 | 0.42 |
| 5426 | Triglycerides in HDL | GCST90497464 | 0.42 |
| 5427 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T132 | ECGA000132 | 0.42 |
| 5428 | Glutamine levels (UKB data field 23461) | GCST90269558 | 0.41 |
| 5429 | ERBB3/IL1R2 ratio | GCST90314689 | 0.41 |
| 5430 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T444 | ECGA000444 | 0.41 |
| 5431 | CDKN2D levels | GCST90468685 | 0.41 |
| 5432 | IDP dMRI TBSS ICVF Posterior corona radiata R | GCST90004353 | 0.41 |
| 5433 | NAGK levels | GCST90469995 | 0.41 |
| 5434 | Insomnia (standard GWA) | GCST90267286 | 0.41 |
| 5435 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 4) | GCST90320567 | 0.41 |
| 5436 | Free cholesterol levels in medium HDL | GCST90132679 | 0.41 |
| 5437 | Drinks usually with meals in current drinkers (yes vs no) (UKB data field 1618) | GCST90132926 | 0.41 |
| 5438 | Monounsaturated fatty acid levels | GCST90499094 | 0.41 |
| 5439 | Bullous keratopathy | FING00000231 | 0.41 |
| 5440 | THTPA levels | GCST90470860 | 0.41 |
| 5441 | Lysophosphatidylcholine (22:0) [sn2] levels | GCST90024176 | 0.41 |
| 5442 | Spread type: Flora Pro-Active/Benecol (UKB data field 1428_2) | GCST90132957 | 0.41 |
| 5443 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T164 | ECGA000164 | 0.41 |
| 5444 | CX3CL1 levels | GCST90241204 | 0.41 |
| 5445 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T114 | ECGU000114 | 0.41 |
| 5446 | Urine 5-acetylamino-6-amino-3-methyluracil levels in chronic kidney disease | GCST90264674 | 0.41 |
| 5447 | HDL x depression interaction (2df test) | GCST90570667 | 0.41 |
| 5448 | AGER levels | GCST90468252 | 0.41 |
| 5449 | aparc-a2009s rh volume G-cuneus | GCST90003009 | 0.41 |
| 5450 | CKAP4/LTBR ratio | GCST90314074 | 0.41 |
| 5451 | Phospholipids in very small VLDL | GCST90500851 | 0.41 |
| 5452 | aseg lh volume Cerebellum-White-Matter | GCST90002618 | 0.41 |
| 5453 | CTSC/PLA2G15 ratio | GCST90314311 | 0.41 |
| 5454 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T94 | ECGA000094 | 0.41 |
| 5455 | ECG, heart rate | ECG during exercise | UKBB00000204 | 0.41 |
| 5456 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T351 | ECGA000351 | 0.41 |
| 5457 | BCAN/NPTXR ratio | GCST90313482 | 0.41 |
| 5458 | ICAM1 levels | GCST90469498 | 0.41 |
| 5459 | Left-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivity | GCST90302718 | 0.41 |
| 5460 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T473 | ECGU000473 | 0.41 |
| 5461 | Hearing aid use | GCST90044774 | 0.41 |
| 5462 | Treatment or medication use - atorvastatin (UKB data field 20003_1141146234) | GCST90042376 | 0.41 |
| 5463 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T59 | ECGA000059 | 0.41 |
| 5464 | aparc-Desikan lh volume parstriangularis | GCST90002787 | 0.41 |
| 5465 | SRC levels | GCST90470741 | 0.41 |
| 5466 | Phospholipids to Total Lipids in Small HDL percentage | GCST90499494 | 0.41 |
| 5467 | Encounter for long-term (current) use of anticoagulants (PheCode 286.2) | GCST90475799 | 0.41 |
| 5468 | CST3 levels | GCST90468894 | 0.41 |
| 5469 | aparc-DKTatlas rh area parsopercularis | GCST90003281 | 0.41 |
| 5470 | Experiencing mood swings | GCST006944 | 0.41 |
| 5471 | Cholesterol to total lipids in medium HDL percentage (UKB data field 23640) | GCST90269737 | 0.41 |
| 5472 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T378 | ECGA000378 | 0.41 |
| 5473 | SLITRK2 levels | GCST90470670 | 0.41 |
| 5474 | HDLBP levels | GCST90087533 | 0.41 |
| 5475 | DTI TBSS MD Sagittal stratum L | GCST90384603 | 0.41 |
| 5476 | Congenital iodine-deficiency syndrome/hypothyroidism | FING00000328 | 0.41 |
| 5477 | Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDL | GCST90093045 | 0.41 |
| 5478 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T156 | ECGU000156 | 0.40 |
| 5479 | SELPLG levels | GCST90012046 | 0.40 |
| 5480 | Cholesteryl Esters in Large VLDL | GCST90498146 | 0.40 |
| 5481 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T266 | ECGA000266 | 0.40 |
| 5482 | Phosphatidylcholine_40:6_[M+H]1+/Phosphatidylethanolamine_43:6_[M+H]1+ levels | GCST90060446 | 0.40 |
| 5483 | Interpolated Age of participant when operation took place | Operations | UKBB00000370 | 0.40 |
| 5484 | Concentration of very large HDL particles (UKB data field 23551) | GCST90269648 | 0.40 |
| 5485 | IDP dMRI TBSS ICVF External capsule R | GCST90004359 | 0.40 |
| 5486 | CTSZ/HSPG2 ratio | GCST90314318 | 0.40 |
| 5487 | Cholesteryl esters to total lipids ratio in small LDL | GCST90092959 | 0.40 |
| 5488 | APP/EGF ratio | GCST90313322 | 0.40 |
| 5489 | Triglycerides to Total Lipids in Medium HDL percentage | GCST90498689 | 0.40 |
| 5490 | Eczema | GCST90468126 | 0.40 |
| 5491 | Total lipid levels in chylomicrons and extremely large VLDL | GCST90093046 | 0.40 |
| 5492 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T308 | ECGU000308 | 0.40 |
| 5493 | Dihomo-linoleoylcarnitine (C20:2) levels | GCST90200144 | 0.40 |
| 5494 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T355 | ECGA000355 | 0.40 |
| 5495 | DTI autoptx L2 ilf r tract | GCST90385181 | 0.40 |
| 5496 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T488 | ECGA000488 | 0.40 |
| 5497 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T257 | ECGA000257 | 0.40 |
| 5498 | HBEGF/LAT2 ratio | GCST90315032 | 0.40 |
| 5499 | ThalamNuclei lh volume PuA | GCST90002720 | 0.40 |
| 5500 | GRP levels | GCST90241242 | 0.40 |
| 5501 | Other and unspecified disorders of vitreous body | FING00000934 | 0.40 |
| 5502 | Leucine levels | GCST90092891 | 0.40 |
| 5503 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T120 | ECGA000120 | 0.40 |
| 5504 | PZP levels | GCST90470399 | 0.40 |
| 5505 | Free cholesterol levels in chylomicrons and extremely large VLDL | GCST90093044 | 0.40 |
| 5506 | SHBG levels | GCST90470622 | 0.40 |
| 5507 | PDGFB/PTPN6 ratio | GCST90315625 | 0.40 |
| 5508 | AXL/GAS6 ratio | GCST90313419 | 0.40 |
| 5509 | Free cholesterol in IDL | GCST90497564 | 0.40 |
| 5510 | PDGFA/SERPINE1 ratio | GCST90315618 | 0.40 |
| 5511 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502389 | 0.40 |
| 5512 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T349 | ECGA000349 | 0.40 |
| 5513 | IDP dMRI TBSS MD Body of corpus callosum | GCST90004030 | 0.40 |
| 5514 | Non-oily fish intake | Diet | UKBB00000525 | 0.40 |
| 5515 | DTI autoptx FA atr l tract | GCST90385114 | 0.40 |
| 5516 | Antihypertensive medication - note that there are other indications | FING00000097 | 0.40 |
| 5517 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T354 | ECGA000354 | 0.40 |
| 5518 | Triglycerides to total lipids ratio in medium HDL | GCST90092903 | 0.40 |
| 5519 | Marzipan liking | GCST90094797 | 0.40 |
| 5520 | Basal metabolic rate (UKB data field 23105) | GCST90468159 | 0.40 |
| 5521 | Coffee difference liking | GCST90094738 | 0.40 |
| 5522 | Other haemoglobinopathies | FING00001053 | 0.40 |
| 5523 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T255 | ECGA000255 | 0.40 |
| 5524 | GKN2 levels | GCST90089413 | 0.40 |
| 5525 | Left eye overall retinal pigment epithelium thickness | GCST90672032 | 0.40 |
| 5526 | Phospholipids in medium HDL (UKB data field 23567) | GCST90269664 | 0.40 |
| 5527 | NOTCH2 levels | GCST90470066 | 0.40 |
| 5528 | Cholesterol in Medium HDL | GCST90498492 | 0.40 |
| 5529 | Cooked vegetables consumption | GCST90132977 | 0.40 |
| 5530 | Omega-6 fatty acids levels | GCST90499177 | 0.40 |
| 5531 | ADGRG2/NRCAM ratio | GCST90313186 | 0.40 |
| 5532 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T353 | ECGA000353 | 0.40 |
| 5533 | total creatine kinase (mean, inv-norm transformed) | GCST90476413 | 0.39 |
| 5534 | Phospholipids in small LDL | GCST90499673 | 0.39 |
| 5535 | THY1/TNFRSF21 ratio | GCST90315919 | 0.39 |
| 5536 | Cholesterol to Total Lipids in Large HDL percentage | GCST90497732 | 0.39 |
| 5537 | STMN3 levels | GCST90242894 | 0.39 |
| 5538 | DHEAS levels | GCST90199673 | 0.39 |
| 5539 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T377 | ECGA000377 | 0.39 |
| 5540 | Fresh fruit intake | Diet | UKBB00000272 | 0.39 |
| 5541 | FAM3D levels | GCST90469188 | 0.39 |
| 5542 | Alcohol usually taken with meals (UKB data field 1618) | GCST90133004 | 0.39 |
| 5543 | Cholesteryl Esters to Total Lipids in Small HDL percentage | GCST90499403 | 0.39 |
| 5544 | Platelet count | GCST90002358 | 0.39 |
| 5545 | Deferral due to hypohemoglobinemia in blood donors | GCST90104113 | 0.39 |
| 5546 | Lysoalkylphosphatidylcholine (O-24:2) levels | GCST90025438 | 0.39 |
| 5547 | CTBS levels | GCST90468900 | 0.39 |
| 5548 | Stroke | GCST006906 | 0.39 |
| 5549 | Triglycerides to Total Lipids in Medium VLDL percentage | GCST90499069 | 0.39 |
| 5550 | CLEC1A levels | GCST90424231 | 0.39 |
| 5551 | rfMRI amplitudes (ICA100 node 45) | GCST90004633 | 0.39 |
| 5552 | Biological Sibling: High cholesterol | GCST90476371 | 0.39 |
| 5553 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T352 | ECGA000352 | 0.39 |
| 5554 | Plasma 1-arachidonoyl-GPE (20:4n6)* levels in chronic kidney disease | GCST90264207 | 0.39 |
| 5555 | Haddock liking | GCST90094776 | 0.39 |
| 5556 | HS6ST1/MEGF9 ratio | GCST90315081 | 0.39 |
| 5557 | Triglycerides in large HDL | GCST90497882 | 0.39 |
| 5558 | CA6/DNER ratio | GCST90313594 | 0.39 |
| 5559 | MANF/NCK2 ratio | GCST90315359 | 0.39 |
| 5560 | PDGFA/PRSS27 ratio | GCST90315616 | 0.39 |
| 5561 | CD80 levels | GCST90468650 | 0.39 |
| 5562 | aparc-a2009s rh area G-occipital-sup | GCST90003390 | 0.39 |
| 5563 | Cardiorespiratory fitness slope | GCST90093320 | 0.39 |
| 5564 | CTSD levels | GCST90468910 | 0.39 |
| 5565 | MAVS/SCAMP3 ratio | GCST90315396 | 0.39 |
| 5566 | Sphinganine-1-phosphate levels | GCST90199845 | 0.39 |
| 5567 | IDP dMRI TBSS OD Tapetum R | GCST90004448 | 0.39 |
| 5568 | AKT1S1/TDRKH ratio | GCST90313233 | 0.39 |
| 5569 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T376 | ECGA000376 | 0.39 |
| 5570 | NUDT16 levels | GCST90470105 | 0.39 |
| 5571 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T229 | ECGU000229 | 0.39 |
| 5572 | NCK2 levels | GCST90470007 | 0.39 |
| 5573 | monocyte (fraction, maximum, inv-norm transformed) | GCST90475508 | 0.39 |
| 5574 | CD46/TIMP1 ratio | GCST90313837 | 0.39 |
| 5575 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T134 | ECGA000134 | 0.39 |
| 5576 | GLB1/PCSK9 ratio | GCST90314933 | 0.39 |
| 5577 | Free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23582) | GCST90269679 | 0.39 |
| 5578 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T493 | ECGU000493 | 0.39 |
| 5579 | Hemoglobin concentration variance | GCST90565685 | 0.39 |
| 5580 | Free cholesterol to total lipids in large HDL percentage (UKB data field 23637) | GCST90269734 | 0.39 |
| 5581 | Principal component-derived dietary pattern 46 | GCST90133051 | 0.39 |
| 5582 | YES1 levels | GCST90471088 | 0.39 |
| 5583 | Free Cholesterol to Total Lipids in Medium VLDL percentage | GCST90498976 | 0.39 |
| 5584 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T413 | ECGU000413 | 0.38 |
| 5585 | COX5B levels | GCST90468834 | 0.38 |
| 5586 | CASP3/PDGFB ratio | GCST90313638 | 0.38 |
| 5587 | ITGB1/REG1A ratio | GCST90315228 | 0.38 |
| 5588 | Triglycerides in small LDL | GCST90499722 | 0.38 |
| 5589 | Facial pigmentation measurement (UV light) | GCST90002283 | 0.38 |
| 5590 | CALCOCO1/CRACR2A ratio | GCST90313598 | 0.38 |
| 5591 | Cholesterol levels in very large HDL | GCST90500310 | 0.38 |
| 5592 | Allergic rhinitis | GCST90086042 | 0.38 |
| 5593 | Arachidoylcarnitine (C20) levels | GCST90200135 | 0.38 |
| 5594 | Cholesteryl Esters in Medium VLDL | GCST90498939 | 0.38 |
| 5595 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T287 | ECGU000287 | 0.38 |
| 5596 | VEGFA levels | GCST90471034 | 0.38 |
| 5597 | IDP dMRI TBSS L3 Cingulum hippocampus L | GCST90004208 | 0.38 |
| 5598 | DVT of lower extremities | FING00000482 | 0.38 |
| 5599 | Leg fat percentage (right) | Impedance measures | UKBB00000392 | 0.38 |
| 5600 | Emotional abuse | GCST90551845 | 0.38 |
| 5601 | Cholesteryl Esters to Total Lipids in Large HDL percentage | GCST90497768 | 0.38 |
| 5602 | MGLL levels | GCST90469901 | 0.38 |
| 5603 | CELA3A/KIRREL2 ratio | GCST90314013 | 0.38 |
| 5604 | IDP dMRI TBSS FA External capsule L | GCST90003910 | 0.38 |
| 5605 | JAM2/TNFRSF19 ratio | GCST90315241 | 0.38 |
| 5606 | Blood cell traits latent factor 5 (platelet) | GCST90559247 | 0.38 |
| 5607 | Phospholipids in small LDL | GCST90499681 | 0.38 |
| 5608 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T491 | ECGA000491 | 0.38 |
| 5609 | Triglycerides to total lipids in medium HDL percentage (UKB data field 23643) | GCST90269740 | 0.38 |
| 5610 | Renal failure | FING00001250 | 0.38 |
| 5611 | CD84/DKK1 ratio | GCST90313911 | 0.38 |
| 5612 | T1 FIRST volume R Puta | GCST90383995 | 0.38 |
| 5613 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T487 | ECGU000487 | 0.38 |
| 5614 | CXCL16/NOTCH1 ratio | GCST90314339 | 0.38 |
| 5615 | CASP10/PRTFDC1 ratio | GCST90313627 | 0.38 |
| 5616 | Free cholesterol levels in very large VLDL | GCST90093020 | 0.38 |
| 5617 | PDGFA levels | GCST90470188 | 0.38 |
| 5618 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T293 | ECGA000293 | 0.38 |
| 5619 | IGFBP1 levels | GCST90469527 | 0.38 |
| 5620 | Phospholipid levels in HDL | GCST90092827 | 0.38 |
| 5621 | Concentration of medium HDL particles | GCST90498622 | 0.38 |
| 5622 | Thick vs thin eyebrows | GCST006093 | 0.38 |
| 5623 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T442 | ECGA000442 | 0.38 |
| 5624 | PRSS27 levels | GCST90470342 | 0.38 |
| 5625 | SPINK6 levels | GCST90470725 | 0.38 |
| 5626 | BMP6 levels | GCST90468454 | 0.38 |
| 5627 | DTI autoptx L2 fmi tract | GCST90385177 | 0.38 |
| 5628 | aparc-a2009s rh area S-parieto-occipital | GCST90003435 | 0.38 |
| 5629 | Takes medication for acid reflux/GERD? | GCST90475321 | 0.38 |
| 5630 | Tachycardia NOS (PheCode 427.7) | GCST90475979 | 0.38 |
| 5631 | IDP dMRI ProbtrackX ICVF slf l | GCST90004396 | 0.38 |
| 5632 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T356 | ECGA000356 | 0.38 |
| 5633 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T496 | ECGU000496 | 0.38 |
| 5634 | Cholesteryl ester levels in small HDL | GCST90092946 | 0.37 |
| 5635 | ADIPOQ levels | GCST90468245 | 0.37 |
| 5636 | Linoleic acid to total fatty acids percentage | GCST90502321 | 0.37 |
| 5637 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502398 | 0.37 |
| 5638 | F11R/PLXNA4 ratio | GCST90314724 | 0.37 |
| 5639 | ERBIN/SNAP29 ratio | GCST90314697 | 0.37 |
| 5640 | BA-exvivo rh volume V2 | GCST90002859 | 0.37 |
| 5641 | HPCAL1 levels | GCST90469471 | 0.37 |
| 5642 | Diabetes (confirmatory factor analysis Factor 28) | GCST90309362 | 0.37 |
| 5643 | aparc-pial rh area fusiform | GCST90003180 | 0.37 |
| 5644 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T445 | ECGA000445 | 0.37 |
| 5645 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T191 | ECGU000191 | 0.37 |
| 5646 | CX3CL1/RGMB ratio | GCST90314327 | 0.37 |
| 5647 | CHMP1A levels | GCST90619002 | 0.37 |
| 5648 | Dermatomycosis (PheCode 110.2) | GCST90475565 | 0.37 |
| 5649 | Average diameter for HDL particles | GCST90497446 | 0.37 |
| 5650 | SVEP1 levels | GCST90242928 | 0.37 |
| 5651 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T486 | ECGU000486 | 0.37 |
| 5652 | PCBD1 levels | GCST90470166 | 0.37 |
| 5653 | ADGRG2/ITGB1 ratio | GCST90313185 | 0.37 |
| 5654 | Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622) | GCST90269719 | 0.37 |
| 5655 | Diastolic blood pressure | GCST90018732 | 0.37 |
| 5656 | Cholesterol levels in chylomicrons and extremely large VLDL | GCST90500905 | 0.37 |
| 5657 | PDGFRB levels | GCST90470192 | 0.37 |
| 5658 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T213 | ECGA000213 | 0.37 |
| 5659 | IDP SWI T2star left putamen | GCST90003867 | 0.37 |
| 5660 | Concentration of very large HDL particles | GCST90093011 | 0.37 |
| 5661 | CA12 levels | GCST90468507 | 0.37 |
| 5662 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T225 | ECGA000225 | 0.37 |
| 5663 | Gonarthrosis | FING00000585 | 0.37 |
| 5664 | PSIP1 levels | GCST90470354 | 0.37 |
| 5665 | Cancer (UKB data field 2453) | GCST90043628 | 0.37 |
| 5666 | Diseases of esophagus (PheCode 530) | GCST90476045 | 0.37 |
| 5667 | Concentration of large HDL particles | GCST90497836 | 0.37 |
| 5668 | CSTB levels | GCST90179272 | 0.37 |
| 5669 | Medication for pain relief, constipation, heartburn - Ibuprofen (e.g. Nurofen) | Medication | UKBB00000455 | 0.37 |
| 5670 | Triacylglycerol_56:5_[M+NH4]1+ levels | GCST90060554 | 0.37 |
| 5671 | IGFBP2 levels | GCST90469528 | 0.37 |
| 5672 | Major dietary changes in the last 5 years - Yes, because of other reasons | Diet | UKBB00000423 | 0.37 |
| 5673 | LILRB1 levels | GCST90469776 | 0.37 |
| 5674 | IZUMO4 levels | GCST90423792 | 0.37 |
| 5675 | Monounsaturated fatty acid levels | GCST90502347 | 0.37 |
| 5676 | DTI autoptx L2 atr r tract | GCST90385169 | 0.37 |
| 5677 | PCDH17/ROBO1 ratio | GCST90315604 | 0.37 |
| 5678 | CDKN1A/DAB2 ratio | GCST90313967 | 0.37 |
| 5679 | Androstenediol (3beta,17beta) disulfate (2) levels | GCST90199851 | 0.37 |
| 5680 | ICOSLG levels | GCST90469503 | 0.37 |
| 5681 | CTSC levels | GCST90468909 | 0.37 |
| 5682 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T411 | ECGU000411 | 0.37 |
| 5683 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T75 | ECGA000075 | 0.37 |
| 5684 | ESAM/SCARF1 ratio | GCST90314715 | 0.37 |
| 5685 | Reticulocyte count | GCST004622 | 0.37 |
| 5686 | Phospholipid levels in large VLDL | GCST90092876 | 0.37 |
| 5687 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T464 | ECGU000464 | 0.37 |
| 5688 | NECTIN2/VSIR ratio | GCST90315533 | 0.36 |
| 5689 | Right-hemisphere salience/ventral attention network to hippocampus white-matter structural connectivity | GCST90302821 | 0.36 |
| 5690 | wg lh intensity-contrast superiorparietal | GCST90003820 | 0.36 |
| 5691 | FABP1/SULT2A1 ratio | GCST90314755 | 0.36 |
| 5692 | Omega-3 fatty acid levels | GCST90502440 | 0.36 |
| 5693 | Principal component-derived dietary pattern 39 | GCST90133044 | 0.36 |
| 5694 | Age started wearing glasses (UKB data field 2217) | GCST90468156 | 0.36 |
| 5695 | Cholesterol levels in large VLDL | GCST90092868 | 0.36 |
| 5696 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T145 | ECGU000145 | 0.36 |
| 5697 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T295 | ECGA000295 | 0.36 |
| 5698 | IDP dMRI TBSS ICVF Cingulum cingulate gyrus L | GCST90004362 | 0.36 |
| 5699 | Certain disorders involving the immune mechanism | FING00000264 | 0.36 |
| 5700 | MET levels | GCST90469895 | 0.36 |
| 5701 | IDP dMRI TBSS L1 Retrolenticular part of internal capsule L | GCST90004096 | 0.36 |
| 5702 | Operative procedures - Fibreoptic endoscopic examination of upper gastrointestinal tract and biopsy of lesion of upper gastrointestinal tract | Summary Operations | UKBB00000578 | 0.36 |
| 5703 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T342 | ECGA000342 | 0.36 |
| 5704 | HPCAL1/LAT ratio | GCST90315072 | 0.36 |
| 5705 | Cholesteryl Esters in Small HDL | GCST90499386 | 0.36 |
| 5706 | ANPEP/CXADR ratio | GCST90313272 | 0.36 |
| 5707 | DTI autoptx MD slf r tract | GCST90385242 | 0.36 |
| 5708 | IGF2R levels | GCST90469526 | 0.36 |
| 5709 | Placental weight (fetal genotype, adjusted for sex) | GCST90275197 | 0.36 |
| 5710 | Ischemic stroke | GCST006908 | 0.36 |
| 5711 | Total fatty acid levels | GCST90500053 | 0.36 |
| 5712 | Lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) levels | GCST90200098 | 0.36 |
| 5713 | Hair colour (natural, before greying) - Black | Sun exposure | UKBB00000295 | 0.36 |
| 5714 | Primary/intrinsic cardiomyopathies (PheCode 425.1) | GCST90475951 | 0.36 |
| 5715 | Plantar fascial fibromatosis | FING00001169 | 0.36 |
| 5716 | SEMA4D/TXNDC5 ratio | GCST90315824 | 0.36 |
| 5717 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T124 | ECGA000124 | 0.36 |
| 5718 | KLK8/WFDC12 ratio | GCST90315259 | 0.36 |
| 5719 | AARSD1/UBAC1 ratio | GCST90313135 | 0.36 |
| 5720 | LRRC59 levels | GCST90469804 | 0.36 |
| 5721 | HDL cholesterol | GCST000755 | 0.36 |
| 5722 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T132 | ECGU000132 | 0.36 |
| 5723 | Phospholipids in very large HDL (UKB data field 23553) | GCST90269650 | 0.36 |
| 5724 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T372 | ECGA000372 | 0.36 |
| 5725 | DAG1/DKK1 ratio | GCST90314373 | 0.36 |
| 5726 | Cholesterol to total lipids in small LDL percentage (UKB data field 23625) | GCST90269722 | 0.36 |
| 5727 | Cholesterol levels in small HDL | GCST90092944 | 0.36 |
| 5728 | DNAJB2 levels | GCST90469013 | 0.36 |
| 5729 | aparc-Desikan rh area parstriangularis | GCST90003126 | 0.36 |
| 5730 | wg lh intensity-contrast frontalpole | GCST90003823 | 0.36 |
| 5731 | Concentration of very small VLDL particles | GCST90500819 | 0.36 |
| 5732 | Neutrophil count | GCST90002352 | 0.36 |
| 5733 | Father's age | Family history | UKBB00000240 | 0.36 |
| 5734 | OLR1 levels | GCST90470122 | 0.36 |
| 5735 | aparc-a2009s rh volume G-cingul-Post-ventral | GCST90003008 | 0.36 |
| 5736 | CCL4 levels | GCST90012052 | 0.36 |
| 5737 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T195 | ECGU000195 | 0.36 |
| 5738 | APP levels | GCST90468344 | 0.36 |
| 5739 | GABARAPL1 levels | GCST90469287 | 0.36 |
| 5740 | Saturated fatty acids to total fatty acids percentage | GCST90502685 | 0.36 |
| 5741 | GERD (PheCode 530.11) | GCST90476047 | 0.36 |
| 5742 | Rubneribacter sp002159915 abundance in stool | GCST90032541 | 0.36 |
| 5743 | Cholesterol to total lipids ratio in very large HDL | GCST90093005 | 0.36 |
| 5744 | CD40/ITGB5 ratio | GCST90313816 | 0.36 |
| 5745 | Left-hemisphere limbic network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302732 | 0.35 |
| 5746 | Pain in thoracic spine | FING00001139 | 0.35 |
| 5747 | 3-hydroxybutyrate levels (UKB data field 23474) | GCST90269571 | 0.35 |
| 5748 | IDP T1 SIENAX white normalised volume | GCST90002432 | 0.35 |
| 5749 | Alzheimer's disease (MTAG) | GCST90449053 | 0.35 |
| 5750 | Triglycerides in VLDL | GCST90500304 | 0.35 |
| 5751 | DEFA1_DEFA1B/LCN2 ratio | GCST90314454 | 0.35 |
| 5752 | Sphingomyelin_38:2_[M+H]1+ levels | GCST90060302 | 0.35 |
| 5753 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T296 | ECGA000296 | 0.35 |
| 5754 | Volume of right anterior amygdaloid area | GCST90474904 | 0.35 |
| 5755 | GSTT2 levels | GCST90086652 | 0.35 |
| 5756 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T122 | ECGA000122 | 0.35 |
| 5757 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T410 | ECGU000410 | 0.35 |
| 5758 | Volume of left whole amygdala | GCST90474986 | 0.35 |
| 5759 | Medication for pain relief, constipation, heartburn - None of the above | Medication | UKBB00000457 | 0.35 |
| 5760 | Total lipids in very large HDL (UKB data field 23552) | GCST90269649 | 0.35 |
| 5761 | IDP dMRI TBSS ICVF Genu of corpus callosum | GCST90004329 | 0.35 |
| 5762 | CSNK1G2 levels | GCST90240608 | 0.35 |
| 5763 | APP/DAG1 ratio | GCST90313320 | 0.35 |
| 5764 | Alkenylphosphatidylethanolamine (P-20:0/18:2) levels | GCST90025683 | 0.35 |
| 5765 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 71) | GCST90320634 | 0.35 |
| 5766 | ANGPTL1 levels | GCST90468302 | 0.35 |
| 5767 | Cholesteryl Esters to Total Lipids in Medium HDL percentage | GCST90498550 | 0.35 |
| 5768 | APRT levels | GCST90468345 | 0.35 |
| 5769 | F9/FURIN ratio | GCST90314747 | 0.35 |
| 5770 | Urticaria | GCST90018716 | 0.35 |
| 5771 | EREG/F2R ratio | GCST90314700 | 0.35 |
| 5772 | Spread type: Butter and margarine vs never use spread (UKB data field 1428) | GCST90132948 | 0.35 |
| 5773 | Left-hemisphere somatomotor network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302678 | 0.35 |
| 5774 | Phosphatidylethanolamine_35:2_[M-H]1- levels | GCST90060260 | 0.35 |
| 5775 | CXADR levels | GCST90468922 | 0.35 |
| 5776 | DPP7 levels | GCST90469035 | 0.35 |
| 5777 | GLB1 levels | GCST90469355 | 0.35 |
| 5778 | Deep vein thrombosis [DVT] (PheCode 452.2) | GCST90476010 | 0.35 |
| 5779 | LACRT levels | GCST90469725 | 0.35 |
| 5780 | GOLGA3 levels | GCST90469375 | 0.35 |
| 5781 | Gout | GCST90399700 | 0.35 |
| 5782 | Omega-3 fatty acid levels | GCST90502064 | 0.35 |
| 5783 | NPTX1 levels | GCST90470078 | 0.35 |
| 5784 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T375 | ECGA000375 | 0.35 |
| 5785 | Triacylglycerol_53:2_[M+NH4]1+ levels | GCST90060531 | 0.35 |
| 5786 | Diacylglycerol_33:1_[M+H-H2O]1+ levels | GCST90060173 | 0.35 |
| 5787 | Type 1 diabetes with ophthalmic manifestations (PheCode 250.13) | GCST90475663 | 0.35 |
| 5788 | DPY30 levels | GCST90469037 | 0.35 |
| 5789 | ARSB levels | GCST90468369 | 0.35 |
| 5790 | IDUA levels | GCST90469508 | 0.35 |
| 5791 | Urine X-23518 levels in chronic kidney disease | GCST90266595 | 0.35 |
| 5792 | Volume of right medial nucleus | GCST90474925 | 0.35 |
| 5793 | Cholesteryl Esters in Large HDL | GCST90497753 | 0.35 |
| 5794 | ODAM levels | GCST90470115 | 0.35 |
| 5795 | PLA2G7 levels | GCST90470249 | 0.35 |
| 5796 | KLK14 levels | GCST90427428 | 0.35 |
| 5797 | IDP T1 SIENAX white unnormalised volume | GCST90002433 | 0.35 |
| 5798 | CCL15 levels | GCST90468567 | 0.35 |
| 5799 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T495 | ECGA000495 | 0.35 |
| 5800 | CD59 levels | GCST90468639 | 0.35 |
| 5801 | ATP5IF1/DECR1 ratio | GCST90313382 | 0.35 |
| 5802 | TDP1 levels | GCST90470826 | 0.35 |
| 5803 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 111) | GCST90320674 | 0.35 |
| 5804 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T196 | ECGU000196 | 0.35 |
| 5805 | METAP1D levels | GCST90469892 | 0.35 |
| 5806 | Malignant neoplasm of bladder (PheCode 189.21) | GCST90475599 | 0.34 |
| 5807 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T85 | ECGU000085 | 0.34 |
| 5808 | Butternut squash liking | GCST90094718 | 0.34 |
| 5809 | X-04499--3,4-dihydroxybutyrate levels | GCST90243497 | 0.34 |
| 5810 | CKMT1A or CKMT1B levels | GCST90468760 | 0.34 |
| 5811 | DDR1/SFTPD ratio | GCST90314443 | 0.34 |
| 5812 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T290 | ECGA000290 | 0.34 |
| 5813 | Principal component-derived dietary pattern 58 | GCST90133061 | 0.34 |
| 5814 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T97 | ECGA000097 | 0.34 |
| 5815 | Total testosterone levels | GCST90503313 | 0.34 |
| 5816 | Systolic blood pressure | GCST90278642 | 0.34 |
| 5817 | VPS53 levels | GCST90471048 | 0.34 |
| 5818 | HEXIM1/TBL1X ratio | GCST90315053 | 0.34 |
| 5819 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T487 | ECGA000487 | 0.34 |
| 5820 | CD38/IL12A_IL12B ratio | GCST90313808 | 0.34 |
| 5821 | Other extrapyramidal and movement disorders in other diseases | FING00001047 | 0.34 |
| 5822 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T62 | ECGA000062 | 0.34 |
| 5823 | Triglycerides in large VLDL | GCST90498267 | 0.34 |
| 5824 | Left ventricular end diastole anterolateral wall thickness | GCST90278517 | 0.34 |
| 5825 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T373 | ECGA000373 | 0.34 |
| 5826 | CASP8/PRDX6 ratio | GCST90313655 | 0.34 |
| 5827 | SIRT2/STAT5B ratio | GCST90315846 | 0.34 |
| 5828 | DTI autoptx FA ilf l tract | GCST90385126 | 0.34 |
| 5829 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 111) | GCST90320930 | 0.34 |
| 5830 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T443 | ECGA000443 | 0.34 |
| 5831 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T80 | ECGA000080 | 0.34 |
| 5832 | DTI TBSS FA Posterior thalamic radiation L | GCST90384409 | 0.34 |
| 5833 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 74) | GCST90320637 | 0.34 |
| 5834 | LPL levels | GCST90469788 | 0.34 |
| 5835 | Total lipids in small HDL | GCST90499456 | 0.34 |
| 5836 | SOD2 levels | GCST90470705 | 0.34 |
| 5837 | Takes medication for Sleep apnea? | GCST90475258 | 0.34 |
| 5838 | EREG/TIMP3 ratio | GCST90314708 | 0.34 |
| 5839 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78) | GCST90320641 | 0.34 |
| 5840 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T131 | ECGA000131 | 0.34 |
| 5841 | ESYT2 levels | GCST90469156 | 0.34 |
| 5842 | Retinal detachments and defects (PheCode 361) | GCST90475845 | 0.34 |
| 5843 | Phospholipids to Total Lipids in Small HDL percentage | GCST90499505 | 0.34 |
| 5844 | Sarcoidosis | GCST90018698 | 0.34 |
| 5845 | Phosphate levels | GCST90200393 | 0.34 |
| 5846 | ENO2/PLXNA4 ratio | GCST90314665 | 0.34 |
| 5847 | Other infective otitis externa | FING00001060 | 0.34 |
| 5848 | GZMA/TNFRSF4 ratio | GCST90315013 | 0.34 |
| 5849 | Total lipids in small HDL | GCST90499443 | 0.34 |
| 5850 | Plasma 4-guanidinobutanoate levels in chronic kidney disease | GCST90264620 | 0.34 |
| 5851 | Omega-3 fatty acids to total fatty acids percentage | GCST90499163 | 0.34 |
| 5852 | EREG/MPI ratio | GCST90314705 | 0.34 |
| 5853 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45) | GCST90320864 | 0.34 |
| 5854 | T1 FreeSurfer aseg Left-Lateral-Ventricle | GCST90384139 | 0.34 |
| 5855 | Right-hemisphere visual network to right-hemisphere default mode network white-matter structural connectivity | GCST90302780 | 0.34 |
| 5856 | Cholesteryl Esters in Small HDL | GCST90499382 | 0.34 |
| 5857 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T361 | ECGA000361 | 0.34 |
| 5858 | SDK2 levels | GCST90470562 | 0.34 |
| 5859 | Deviated nasal septum | FING00000409 | 0.34 |
| 5860 | Seminoma of testis, excluding all cancers (controls excluding all cancers) | FING00001289 | 0.34 |
| 5861 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T71 | ECGA000071 | 0.34 |
| 5862 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T348 | ECGA000348 | 0.34 |
| 5863 | DCBLD2/PLA2G15 ratio | GCST90314428 | 0.34 |
| 5864 | Left-hemisphere somatomotor network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302677 | 0.34 |
| 5865 | CXCL10 levels | GCST90468923 | 0.33 |
| 5866 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T84 | ECGU000084 | 0.33 |
| 5867 | Triglycerides to total lipids in large HDL percentage (UKB data field 23638) | GCST90269735 | 0.33 |
| 5868 | CSNK2A1 levels | GCST90468889 | 0.33 |
| 5869 | Cholesterol levels in very small VLDL | GCST90500700 | 0.33 |
| 5870 | Principal component-derived dietary pattern 26 | GCST90133031 | 0.33 |
| 5871 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T242 | ECGA000242 | 0.33 |
| 5872 | pro-brain natriuretic peptide (proBNP, mean, inv-norm transformed) | GCST90476312 | 0.33 |
| 5873 | Histidine levels | GCST90497481 | 0.33 |
| 5874 | Omega-3 fatty acids to total fatty acids percentage | GCST90502451 | 0.33 |
| 5875 | CD244 levels | GCST90274771 | 0.33 |
| 5876 | Chronic obstructive pulmonary disease in current smokers | GCST90016593 | 0.33 |
| 5877 | LTBR levels | GCST90469816 | 0.33 |
| 5878 | Triacylglycerol_56:7_[M+NH4]1+ levels | GCST90060551 | 0.33 |
| 5879 | Free cholesterol levels in HDL | GCST90092824 | 0.33 |
| 5880 | Acquired toe deformities (PheCode 735.2) | GCST90476249 | 0.33 |
| 5881 | LCN2/S100A12 ratio | GCST90315309 | 0.33 |
| 5882 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T374 | ECGA000374 | 0.33 |
| 5883 | PPL levels | GCST90470294 | 0.33 |
| 5884 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T342 | ECGU000342 | 0.33 |
| 5885 | PFKM levels | GCST90618802 | 0.33 |
| 5886 | Myocardial fractal dimension (slice 6) | GCST90000292 | 0.33 |
| 5887 | T1 FreeSurfer aseg Right-choroid-plexus | GCST90384170 | 0.33 |
| 5888 | Free cholesterol to total lipids in large VLDL percentage (UKB data field 23592) | GCST90269689 | 0.33 |
| 5889 | Sarcoidosis | FING00001275 | 0.33 |
| 5890 | Anomalies of dental arch relationship, including avohilmo | FING00000091 | 0.33 |
| 5891 | wg lh intensity-contrast parahippocampal | GCST90003807 | 0.33 |
| 5892 | TMEM25 levels | GCST90470888 | 0.33 |
| 5893 | CD58/MEGF10 ratio | GCST90313853 | 0.33 |
| 5894 | NECTIN4 levels | GCST90470021 | 0.33 |
| 5895 | Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers) | FING00000864 | 0.33 |
| 5896 | CD248 levels | GCST90468612 | 0.33 |
| 5897 | FABP5/PPCDC ratio | GCST90314763 | 0.33 |
| 5898 | KHK levels | GCST90469675 | 0.33 |
| 5899 | T1 FreeSurfer DK lh precentral thickness | GCST90385645 | 0.33 |
| 5900 | Cholesteryl Esters to Total Lipids in Large VLDL percentage | GCST90498162 | 0.33 |
| 5901 | HEXIM1 levels | GCST90469447 | 0.33 |
| 5902 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T56 | ECGA000056 | 0.33 |
| 5903 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T467 | ECGU000467 | 0.33 |
| 5904 | NH4_C22:4 Cholesteryl ester levels in chronic kidney disease | GCST90257227 | 0.33 |
| 5905 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502410 | 0.32 |
| 5906 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T446 | ECGA000446 | 0.32 |
| 5907 | Infantile hypertrophic pyloric stenosis | GCST006705 | 0.32 |
| 5908 | Plasma X-26054 levels in chronic kidney disease | GCST90266858 | 0.32 |
| 5909 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T294 | ECGA000294 | 0.32 |
| 5910 | GPC1/ITGB6 ratio | GCST90314977 | 0.32 |
| 5911 | GLOD4/HSPA1A ratio | GCST90314937 | 0.32 |
| 5912 | X-23641 levels | GCST90200603 | 0.32 |
| 5913 | CSF3R levels | GCST90468885 | 0.32 |
| 5914 | IDP dMRI ProbtrackX L1 slf r | GCST90004268 | 0.32 |
| 5915 | Right-hemisphere somatomotor network to caudate white-matter structural connectivity | GCST90302795 | 0.32 |
| 5916 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T227 | ECGU000227 | 0.32 |
| 5917 | AXIN1/HEXIM1 ratio | GCST90313408 | 0.32 |
| 5918 | F-sauces liking (derived food-liking factor) | GCST90094831 | 0.32 |
| 5919 | Oral glucose tolerance test-1h | GCST90297789 | 0.32 |
| 5920 | LAT2/SDC4 ratio | GCST90315278 | 0.32 |
| 5921 | AIFM1/SIRT2 ratio | GCST90313221 | 0.32 |
| 5922 | T1 FreeSurfer DK rh cuneus volume | GCST90385761 | 0.32 |
| 5923 | hemoglobin (mean, inv-norm transformed) | GCST90475374 | 0.32 |
| 5924 | NBL1 levels | GCST90470001 | 0.32 |
| 5925 | LRTM2 levels | GCST90469808 | 0.32 |
| 5926 | Triglycerides to Total Lipids in Large HDL percentage | GCST90497896 | 0.32 |
| 5927 | CFHR1 levels | GCST90618503 | 0.32 |
| 5928 | Colorectal cancer | GCST90018588 | 0.32 |
| 5929 | SIRPA levels | GCST90470639 | 0.32 |
| 5930 | IDP dMRI TBSS OD External capsule R | GCST90004434 | 0.32 |
| 5931 | Neuroticism | GCST005232 | 0.32 |
| 5932 | Biliverdin levels in chronic kidney disease | GCST90257495 | 0.32 |
| 5933 | VEGFB levels | GCST90471035 | 0.32 |
| 5934 | PLA2G2A levels | GCST90470247 | 0.32 |
| 5935 | SIAE levels | GCST90470629 | 0.32 |
| 5936 | Left-hemisphere default mode network to right-hemisphere control network white-matter structural connectivity | GCST90302765 | 0.32 |
| 5937 | Radial styloid tenosynovitis [de Quervain] | FING00001237 | 0.32 |
| 5938 | HRG levels | GCST90469476 | 0.32 |
| 5939 | CXCL11 levels | GCST90274781 | 0.32 |
| 5940 | Treatment or medication use - rosuvastatin (UKB data field 20003_1141192410) | GCST90042539 | 0.32 |
| 5941 | CDC42BPB levels | GCST90468666 | 0.32 |
| 5942 | Plum liking | GCST90094812 | 0.32 |
| 5943 | rfMRI amplitudes (ICA100 node 15) | GCST90004603 | 0.32 |
| 5944 | NTRK3/SCARF2 ratio | GCST90315571 | 0.32 |
| 5945 | Otitis externa, unspecified | FING00001129 | 0.32 |
| 5946 | Phenylalanine levels (UKB data field 23468) | GCST90269565 | 0.32 |
| 5947 | Docosahexaenoic acid to total fatty acids percentage | GCST90501997 | 0.32 |
| 5948 | Bicuspidal aortic valve syndrome | FING00000212 | 0.32 |
| 5949 | Childhood maltreatment | GCST90551832 | 0.32 |
| 5950 | CCL11/CCL13 ratio | GCST90313671 | 0.32 |
| 5951 | APOB/APOA1 ratio | GCST90269538 | 0.32 |
| 5952 | Free cholesterol in very small VLDL | GCST90500774 | 0.32 |
| 5953 | CD99/RELT ratio | GCST90313930 | 0.32 |
| 5954 | Triglycerides to total lipids ratio in large HDL | GCST90092855 | 0.32 |
| 5955 | MTHFSD levels | GCST90469956 | 0.32 |
| 5956 | CD84/VASH1 ratio | GCST90313920 | 0.32 |
| 5957 | BDNF levels | GCST90468437 | 0.32 |
| 5958 | FKBP4 levels | GCST90469243 | 0.32 |
| 5959 | Pulmonary embolism | FING00001228 | 0.31 |
| 5960 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T79 | ECGA000079 | 0.31 |
| 5961 | Phospholipids in very small VLDL | GCST90500840 | 0.31 |
| 5962 | MYOC/RGMB ratio | GCST90315508 | 0.31 |
| 5963 | Arthropathy in ulcerative colitis | FING00000110 | 0.31 |
| 5964 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T471 | ECGU000471 | 0.31 |
| 5965 | TF levels | GCST90470841 | 0.31 |
| 5966 | IDP T1 FAST ROIs L cerebellum VI | GCST90002566 | 0.31 |
| 5967 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T139 | ECGU000139 | 0.31 |
| 5968 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T344 | ECGA000344 | 0.31 |
| 5969 | IDP dMRI TBSS MO Medial lemniscus L | GCST90003961 | 0.31 |
| 5970 | HEPH levels | GCST90469446 | 0.31 |
| 5971 | Whole body fat free mass (UKB data field 23101) | GCST90428120 | 0.31 |
| 5972 | FAM20A levels | GCST90469185 | 0.31 |
| 5973 | Phospholipids in small HDL | GCST90499478 | 0.31 |
| 5974 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T362 | ECGA000362 | 0.31 |
| 5975 | COX5B/METAP1D ratio | GCST90314201 | 0.31 |
| 5976 | LAMA4/PDGFB ratio | GCST90315273 | 0.31 |
| 5977 | CXCL8 levels | GCST90468934 | 0.31 |
| 5978 | PITHD1 levels | GCST90470239 | 0.31 |
| 5979 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T306 | ECGA000306 | 0.31 |
| 5980 | MYH9 levels | GCST90469975 | 0.31 |
| 5981 | Cholesteryl ester levels in very large HDL | GCST90093006 | 0.31 |
| 5982 | IDP dMRI TBSS L2 Posterior limb of internal capsule L | GCST90004142 | 0.31 |
| 5983 | Platelet count | GCST90018749 | 0.31 |
| 5984 | CRKL/DBNL ratio | GCST90314263 | 0.31 |
| 5985 | Behaviour of cancer tumour: malignant, primary site, PHESANT recoding (UKB data field 40012_3) | GCST90043946 | 0.31 |
| 5986 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T292 | ECGU000292 | 0.31 |
| 5987 | Total lipids in medium HDL | GCST90498604 | 0.31 |
| 5988 | CEP43/PLXNB3 ratio | GCST90314020 | 0.31 |
| 5989 | NME3 levels | GCST90470055 | 0.31 |
| 5990 | Telomere length (principal component 2) | GCST90435145 | 0.31 |
| 5991 | NUDT5 levels | GCST90470107 | 0.31 |
| 5992 | IL6ST/PDGFRA ratio | GCST90315169 | 0.31 |
| 5993 | Belief that own life is meaningful | Happiness and subjective well-being | UKBB00000090 | 0.31 |
| 5994 | ICD10 C50.9: Malignant neoplasm of breast of unspecified site | GCST90043889 | 0.31 |
| 5995 | ICD10 N91.0, N91.1, N91.2: Amenorrhea, including primary amenorrhea, secondary amenorrhea and unspecified amenorrhea | GCST90454219 | 0.31 |
| 5996 | CRYBB2 levels | GCST90468875 | 0.31 |
| 5997 | Esophagitis, GERD and related diseases (PheCode 530.1) | GCST90476046 | 0.31 |
| 5998 | RLN2 levels | GCST90470474 | 0.31 |
| 5999 | Main speciality of consultant (recoded) - General surgery | Summary Administration | UKBB00000417 | 0.31 |
| 6000 | Volume of left anterior amygdaloid area | GCST90474937 | 0.31 |